Risk factors and outcomes of nocardiosis in hematopoietic stem cell transplantation recipients
Orforglipron is a pill
Per AAPC's classification, it uses K22.2 for a structural obstruction or K22.4 for a motility disorder like achalasia or spasm
Nh , n gip lm chm qu trnh lo ha, gim np nhn v duy tr n hi cho da
Quality-control note Because DSIP is research-use only, batch-level COA review and supplier verification matter
The following have also been reported: Central Nervous System: confusion, depression, dysarthria, headache, slurred speech, tremor, vertigo Gastrointestinal System: constipation, nausea, gastrointestinal disturbances Special Senses: blurred vision, diplopia, dizziness Cardiovascular System: hypotension Psychiatric and Paradoxical Reactions: stimulation, restlessness, acute hyperexcited states, anxiety, agitation, aggressiveness, irritability, rage, hallucinations, psychoses, delusions, increased muscle spasticity, insomnia, sleep disturbances, and nightmares